REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Form 10-K Annual Reports
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: RVPH
CIK: 1742927
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerDerek Dowsett
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | 2026-08-13 | — | SCHEDULE 13G/A Filing | 0000312069-26-000222 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | FORM 10-Q | 0001437749-26-027358 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | FORM 8-K | 0001437749-26-027356 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-03 | — | SCHEDULE 13G/A Filing | 0001104659-26-089899 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-31 | — | SCHEDULE 13G/A Filing | 0001610520-26-000096 | View SEC Doc Filr Page |
| 25-NSE | 2026-07-10 | — | 25-NSE Filing | 0001354457-26-000658 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001649553-26-000058 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-14 | — | SCHEDULE 13G Filing | 0000312069-26-000174 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | FORM 10-Q | 0001437749-26-016762 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-13 | FORM 8-K | 0001437749-26-016760 | View SEC Doc Filr Page |
| 8-K | 2026-05-13 | 2026-05-12 | FORM 8-K | 0001437749-26-016538 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-05-07 | — | SCHEDULE 13G Filing | 0001610520-26-000060 | View SEC Doc Filr Page |
| 8-K | 2026-04-15 | 2026-04-15 | FORM 8-K | 0001437749-26-012303 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-03-30 | — | SCHEDULE 13G Filing | 0001104659-26-036874 | View SEC Doc Filr Page |
| S-8 | 2026-03-30 | — | FORM S-8 | 0001437749-26-010181 | View SEC Doc Filr Page |
| 8-K | 2026-03-30 | 2026-03-30 | FORM 8-K | 0001437749-26-010140 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | FORM 10-K | 0001437749-26-010126 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-03-25 | — | SCHEDULE 13G Filing | 0001649553-26-000036 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-03-24 | — | SCHEDULE 13D/A Filing | 0001493152-26-012362 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-18 | FORM 4 | 0001437749-26-009260 | View SEC Doc Filr Page |
| 4 | 2026-03-20 | 2026-03-18 | FORM 4 | 0001437749-26-009258 | View SEC Doc Filr Page |
| 8-K | 2026-03-19 | 2026-03-18 | FORM 8-K | 0001437749-26-009063 | View SEC Doc Filr Page |
| 424B5 | 2026-03-19 | — | FORM 424B5 | 0001437749-26-009062 | View SEC Doc Filr Page |
| 424B5 | 2026-03-18 | — | FORM 424B5 | 0001437749-26-008843 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-03-04 | FORM 8-K | 0001437749-26-006991 | View SEC Doc Filr Page |